ConductScience.org, home

Gene · 2215

Papers2,393

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,393

Download this page as JSON
TitleJournalYearPMIDFound bySource
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy.Front Immunol202540191207PubTator, text miningPubMed
Enhancing activity of FcαRI-bispecific antibodies using glycoengineering.J Immunol202540156381PubTator, text miningPubMed
DNA methylation-predicted plasma protein levels and breast cancer risk.Breast Cancer Res202540140843PubTator, text miningPubMed
Molecular crosstalk and potential causal mechanisms of rheumatoid arthritis and sarcopenia co-morbidity: A gene integration analysis.Exp Gerontol202540081680PubTator, text miningPubMed
Identification and validation of palmitoylation-related biomarkers in gestational diabetes mellitus.Sci Rep202540055514PubTator, text miningPubMed
Predicting interactome networks of up/down regulated proteins and drug-gene interaction analysis associated with peri-implantitis.Dent Res J (Isfahan)202540028501PubTator, text miningPubMed
Comprehensive transcriptomics analysis of peripheral blood mononuclear cells in exposure to mustard gas.Int Immunopharmacol202539946765PubTator, text miningPubMed
Fc gamma receptors activate different protein kinase C isoforms in human neutrophils.J Leukoc Biol202539946245PubTator, text miningPubMed
Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity.PLoS One202539928675PubTator, text miningPubMed
RNAseq of peripheral blood mononucleated cells exposed to platelet-rich fibrin and enamel matrix derivatives.Sci Rep202539881164PubTator, text miningPubMed
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process.MAbs202539819511PubTator, text miningPubMed
Identification of possible drug treatment targets and related immune cell infiltration properties in acute myeloid leukemia utilizing robust rank aggregation algorithm.Leuk Lymphoma202539813619PubTator, text miningPubMed
Elucidating the molecular association and potential mechanisms between psoriasis and atrial fibrillation through biomarker and immune infiltration analysis.Arch Dermatol Res202539776247PubTator, text miningPubMed
Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.mBio202539660921PubTator, text miningPubMed
Illuminating the enigmatic pathogenesis of Kawasaki disease: Unveiling novel therapeutic avenues by targeting FCGR3B-S100A12 pathway.Eur J Pharmacol202539631652PubTator, text miningPubMed
Therapeutic targets for gastrointestinal diseases: proteome-wide Mendelian randomization and colocalization analyses.Postgrad Med J202539400547PubTator, text miningPubMed
Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver Diseases.Cell Mol Gastroenterol Hepatol202539349248PubTator, text miningPubMed
Multiomic analysis reveals cellular, transcriptomic and epigenetic changes in intestinal pouches of ulcerative colitis patients.medRxiv202538014192PubTator, text miningPubMed
Investigating potential drug targets for IgA nephropathy and membranous nephropathy through multi-queue plasma protein analysis: a Mendelian randomization study based on SMR and co-localization analysis.
BioData Min202439516845PubTator, text miningPubMed
Differential gene expression of immune response in COVID-19 and its relationship with progression of COVID-19.Hum Immunol202439418742PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2215/papers?page=5